Globe News Wire
21 Mar 2026, 14:30 UTC · 27w ago
Verdict
Headline takes no side. We score IBAB.BR +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 89% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
IBA has launched myQA MatriXX AiR, the first commercially available wireless 2D ionization chamber array for patient-specific QA in particle therapy.
More positive than 79% of claims this week
The new system is designed to support next-generation radiotherapy techniques, specifically FLASH and ARC radiotherapy.
So whatPositioning the product as 'future-proof' for emerging high-dose rate techniques allows IBA to capture early adoption cycles as clinics upgrade their technology.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
More positive than 67% of claims this week
The MatriXX AiR features 1,521 high-resolution air-vented ionization chambers capable of delivering 2D dose distribution readouts within seconds.
More positive than 54% of claims this week
Which stocks this story touches
More positive than 89% of ticker scores this week
The company launched a first-of-its-kind wireless ionization chamber array, strengthening its leadership in particle therapy quality assurance.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
2h ago
—
No price for IBAB.BR right now — the quote feed didn't answer.
IBAB.BR chart →
